iCAD Overview
- Year Founded
-
1984
- Status
-
Acquired/Merged
- Employees
-
66
- Latest Deal Type
-
M&A
- Financing Rounds
-
13
- Investments
-
8
iCAD General Information
Description
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
Contact Information
Website
www.icadmed.com(Operating Subsidiary)
Corporate Office
- 2 Townsend West
- Suite 6
- Nashua, NH 03063
- United States
Corporate Office
- 2 Townsend West
- Suite 6
- Nashua, NH 03063
- United States
iCAD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
iCAD Comparisons
Industry
Financing
Details
iCAD Competitors (18)
One of iCAD’s 18 competitors is Varian Medical Systems, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Varian Medical Systems | Venture Capital-Backed | Palo Alto, CA | ||||
| P-Cure | Venture Capital-Backed | Shilat, Israel | ||||
| Synaptive Medical | Formerly VC-backed | Mississauga, Canada | ||||
| Sun Nuclear | Formerly PE-Backed | Melbourne, FL | ||||
| ContextVision | Corporation | Stockholm, Sweden |
iCAD Patents
iCAD Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019384179-A1 | System and method for assessing breast cancer risk using imagery | Inactive | 23-Nov-2018 | ||
| AU-2025204096-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
| EP-3884458-A1 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
| EP-3884458-A4 | System and method for assessing breast cancer risk using imagery | Pending | 23-Nov-2018 | ||
| US-11205265-B2 | System and method for assessing breast cancer risk using imagery | Active | 23-Nov-2018 | G06Q50/163 |
iCAD Signals
iCAD Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
iCAD Acquisitions (8)
iCAD’s most recent deal was a Merger/Acquisition with VuCOMP for . The deal was made on 13-Jan-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| VuCOMP | 13-Jan-2016 | Merger/Acquisition | Monitoring Equipment | ||
| VuCOMP (Breast Density software) | 29-Apr-2015 | Merger/Acquisition | Decision/Risk Analysis | ||
| DermEbx | 15-Jul-2014 | Merger/Acquisition | Therapeutic Devices | ||
| Radion | 15-Jul-2014 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Xoft | 30-Dec-2010 | Merger/Acquisition | Other Devices and Supplies |
iCAD Exits (1)
iCAD’s most recent exit was on 30-Dec-2010 from Xoft. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Xoft | 30-Dec-2010 | Completed |
|
iCAD Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Cadx Systems | Beavercreek, OH | 2002 | |
| Qualia Computing | Beavercreek, OH | 1997 |
iCAD FAQs
-
When was iCAD founded?
iCAD was founded in 1984.
-
Where is iCAD headquartered?
iCAD is headquartered in Nashua, NH.
-
What is the size of iCAD?
iCAD has 66 total employees.
-
What industry is iCAD in?
iCAD’s primary industry is Diagnostic Equipment.
-
Is iCAD a private or public company?
iCAD is a Private company.
-
What is the current valuation of iCAD?
The current valuation of iCAD is .
-
What is iCAD’s current revenue?
The current revenue for iCAD is .
-
How much funding has iCAD raised over time?
iCAD has raised $45.4M.
-
Who are iCAD’s investors?
Biobrit, Bonanza Capital, Cranshire Capital Advisors, Deephaven Capital Management, and Deerfield Management are 5 of 7 investors who have invested in iCAD.
-
Who are iCAD’s competitors?
Varian Medical Systems, P-Cure, Synaptive Medical, Sun Nuclear, and ContextVision are some of the 18 competitors of iCAD.
-
When was iCAD acquired?
iCAD was acquired on 17-Jul-2025.
-
Who acquired iCAD?
iCAD was acquired by DeepHealth (Healthcare Technology Systems).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process